$BSX

AI 分析

生成于 May 11, 2026

AI Score
76/ 100
Buy$BSX

Boston Scientific Corporation

$BSXNYSEHealthcareLarge-Cap

Boston Scientific develops medical devices for interventional cardiology, cardiac rhythm management, neuromodulation, and endoscopy.

Market Cap
$120.0B
Revenue (TTM)
$16.5B
+18.0%
Net Income (TTM)
$2.2B
+25.0%
EPS (TTM)
$1.50
P/E Ratio
55.0
Dividend Yield
0.0%
52-Week Range
$55-$95
Beta
0.82
Dimension Scores
Fundamental
72
Technical
72
Sentiment
78
Risk / Reward
72
Momentum
78
FundTechSentRiskMome
Financial Health
Profitability
77strong
Growth
81strong
Liquidity
80strong
Solvency
74strong
Efficiency
70strong

Valuation, technical analysis, investment thesis, risk assessment and more for $BSX

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。